JPMorgan Chase & Co. Analysts Give Gerresheimer (ETR:GXI) a €68.90 Price Target

Gerresheimer (ETR:GXIGet Rating) has been given a €68.90 ($74.89) price objective by JPMorgan Chase & Co. in a research report issued to clients and investors on Wednesday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s target price suggests a potential upside of 2.30% from the company’s previous close.

A number of other research analysts have also commented on the stock. Credit Suisse Group set a €89.00 ($96.74) price objective on shares of Gerresheimer in a research note on Thursday, February 17th. Deutsche Bank Aktiengesellschaft set a €115.00 ($125.00) price objective on shares of Gerresheimer in a research note on Friday, February 18th. Deutsche Bank Rese… set a €115.00 ($125.00) price objective on shares of Gerresheimer in a research note on Friday, April 8th. Finally, The Goldman Sachs Group set a €110.00 ($119.57) price objective on shares of Gerresheimer in a research note on Thursday, April 7th.

Shares of ETR:GXI opened at €67.35 ($73.21) on Wednesday. The company’s fifty day moving average price is €68.21 and its 200 day moving average price is €76.27. Gerresheimer has a 12 month low of €53.45 ($58.10) and a 12 month high of €99.40 ($108.04). The company has a debt-to-equity ratio of 113.12, a current ratio of 0.74 and a quick ratio of 0.42. The firm has a market capitalization of $2.11 billion and a P/E ratio of 25.24.

Gerresheimer Company Profile (Get Rating)

Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices.

Read More

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.